Abstract
Guidelines for patients with ST-elevation myocardial infraction (STEMI) recommend primary percutaneous coronary intervention (PCI) with a door-to-balloon (D2B) time 90 minutes when presenting directly to a PCI-capable hospital. 1 In 2006, the American College of Cardiology started D2B: An Alliance in Quality and set a goal of 75% of patients having a D2B time 90
minutes. 2 Since then, time to treatment for STEMI patients at PCI hospitals has improved dramatically, in particular for patients using EMS with access to pre-hospital electrocardiograms. 3, 4 Patients who develop STEMI after admission to the hospital are a unique population typically excluded from clinical trials, registries, and quality reporting. This patient population has not been well characterized with only 5 previous reports describing patients who develop acute MI while in-hospital, 2 of which were published prior to 1990. Only 1 small report explicitly evaluated in-hospital STEMI patients. Therefore we examined the clinical characteristics, time to treatment and clinical outcomes of patients who develop STEMI after a hospital admission.
Methods
The Minneapolis Heart Institute at Abbott Northwestern (ANW) Hospital is a tertiary cardiovascular center with referral relationships with community hospitals throughout Minnesota and western Wisconsin. In 2003, a regional STEMI system, the "Level 1 MI program" was initiated using a standardized protocol for transfer of STEMI patients designed to improve time to treatment and clinical outcomes in patients with STEMI presenting to community hospitals without PCI capability. The system design and early results of the program have previously been published. 5, 6 Thirty-one regional hospitals participate, including 11 hospitals within 60 miles of has not been well characterized with only 5 previous reports describing patients wh wh who o o de de deve ve velo lo lop p p acute MI while in-hospital, 2 of which were published prior to 1990. Only 1 small report ex xpl pl plic ic icit it itl ly ly e e eva va valuat at te ed ed in-hospital STEMI patients. T T Th h herefore we ex xam a a in ned ed ed t the clinical h ch har r arac a teristics, s t tim im ime to to o t tr re reat at atme me ment nt a a and nd nd c c cli in nica a al o outc c co om mes s s o o of f p pa pati tien en nts s w who ho ho d d dev ev vel el elop op S S STE TE TEM MI M a a af ft fte e er a a ho hosp sp spit it ital al a a adm dm dmi is issi sion on on. . Standardized protocols and a predetermined transfer plan (ambulance or helicopter on the basis of locations and availability) are in place for each site. Inclusion criteria include all patients with ST-elevation or new left bundle branch block with symptoms <24 hours including patients suffering out-of-hospital cardiac arrest, cardiogenic shock, intubation, comorbid illnesses, and the elderly. All patients are enrolled in a comprehensive prospective database with cardiovascular rehospitalization and major adverse cardiac events (MACE) including all-cause mortality, nonfatal reinfarction, repeat revascularization, and stroke assessed in all patients inhospital, at 30 days, and at 1 year, as well as mortality at 5 years.
We recognized that patients who develop STEMI after hospital admission were high risk and frequently not recognized or reported, therefore beginning in 2010, the standardized Level 1
protocol was applied to in-hospital patients. Post-implementation, 57 in-hospital STEMI patients
were identified compared to only 26 patients who were identified pre-implementation.
Prospective data on STEMI patients treated between March 1, 2003 and January 1, 2013 was queried from the database. For primary analysis, mode of arrival was extracted for all patients who presented directly to the PCI facility, with patients subsequently placed into 1 of 3 categories: arrival via EMS, self/family driven, or in-hospital presentation. For secondary analysis, electronic medical records were reviewed for all patients who had in-hospital presentation and reason for initial admission was recorded. Baseline demographics, cardiovascular risk factors, angiographic and clinical characteristics, procedural and time data, and outcomes were analyzed. For patients who arrived via EMS or were self/family driven, doorto-balloon times were calculated. For in-hospital patients, diagnostic EKG-to-balloon times were used as surrogates for door-to-balloon times. Length of stay (LOS) was defined as date of
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Baseline and angiographic characteristics of in-hospital patients can be found in Table 1 with comparisons to patients who arrived via EMS or were self/family driven. In-hospital patients were older, had a larger BMI, higher rates of hypertension, were more likely to have a history of CAD, and presented more frequently with cardiac arrest, cardiogenic shock, or have a Killip class of 2, 3 or 4 compared to patients who presented to the emergency department ED.
TIMI flow pre and post PCI, infarct size and location were similar between groups.
Board approval was obtained for data collection, follow-up, and data analysis.
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There were 49 patients in the cardiac admission group including ACS, post-PCI, ventricular fibrillation, clinical stress testing, stroke, and 2 of the miscellaneous patients with heart failure and an embolic event. There were 34 patients in the non-cardiac admission group including postsurgery, respiratory failure, and 4 of the miscellaneous patients with cancer (n=2) and gastrointestinal (n=2 vs. 30.8%; p=0.022). Numerically lower rates of mortality in-hospital and at 30 days and decreased diagnostic EKG to balloon times were also noted, but did not reach statistical significance due to small numbers.
Discussion
To our knowledge, this is the largest report of patients who developed STEMI after hospital admission and the first description of the application of a standardized, in-hospital STEMI protocol. Insights into why these patients were initially admitted and how they differ from year, while pa pa pati ti tien en ents ts ts w w who ho ho d dev ev evel e e op op oped ed e S S STE TE TEMI MI MI f f fol ol o lo lo l wi wi w ng ng ng r res es espi pi pira ra rato to tory ry ry f f fai ai a lu lu lur r re e e (r (r (ran an a ge ge ge 3 3 34-4-4 26 26 2 7 minutes) ) ) overall mortality rate of 29% for 55 patients who sustained a Q-wave AMI while in-hospital. 8 In 5.3% vs. 5.4%, 1 year: 10.5% vs. 9.4%).
Regional STEMI systems using standardized protocols have been reported to improve time to treatment, decrease eligible but untreated, decrease gender and age discrepancies and comorbidities, longer reperfusion times, and increased in-hospital mortality (39. .6% 6% 6% vs s. . 3 3 3.9 .9 9%) % %), , a difference that persisted even after adjusting for comorbidities, compared to patients who Our study has limitations in that it is a single-center experience, and although data is collected prospectively, it is obtained from a registry. Also, it is possible that centers with a less aggressive reperfusion strategy may obtain different results. Although this is the largest population of in-hospital STEMI patients to our knowledge, the sample size is still small, making it difficult to draw concrete conclusions. In the years prior to the implementation of our inhospital STEMI protocol, it is likely that in-hospital patients were missed, both patients who
were not recognized and those not reported as STEMI. Finally, reperfusion times may be underestimated for in-hospital STEMI patients since we used "diagnostic EKG" as a surrogate
for the "door" onset time.
Conclusion
Patients who develop STEMI while in-hospital are a complex, heterogeneous population.
Overall, these patients have increased comorbidities, time to reperfusion and 1-year mortality. In utilized including adjunctive medications (aspirin, P2Y12 inhibitors, heparin).
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